Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.